Pete what chart are you looking at because I see the Nasdaq composite volume lower today. I bought a trial position in Ever and YUMC.
Ever
Even the S&P volume was lower
1 Like
It’s still a chunk of money, not sure it’s worth it. From some of the lists I have seen in a variety of areas, a lot of it is basic technical analysis. It just organizes it from an IBD perspective with their unique phrasing. Nothing wrong with that, just not sure it gains much. Would be great if anyone has bought it chimed in and discussed advantages. Note, from Black Friday until a month or so ago, it was 50% off. Didn’t bite then either. But I’m not looking for a system to follow, just looking at systems to incorporate bits and pieces that work with what I do.
I’m still completing my IBD Live 3 moths for $9.95 plus another free 3 months when I asked to cancel. I probably will buy a year when it ends. I can’t begin to watch it all but I catch enough and get tidbits from all their “schools” to make it worthwhile. They make references and comments based on all of their products all the time and have guests on Fridays that discuss their perspective and techniques. Those are the ones I try to watch.
Mike Webster has started a Youtube series called “Webby Rambles On” or WRO. And boy, does he ever!! But it really goes through a lot of the detail. But I’ve learned to watch at 2X speed and slow when he starts to say something I need to hear. Some of them are 2 1/2 hours long!!!
The difficulty is trying to learn too many things. Focus on approaches that work for you and make sense to you. You can’t try to master ten different approaches but often they have different techniques that overlap with your approach and work together with it.
Happy hunting,
Lakedog
1 Like
Andy,
It turns out I was looking at Price Chage on the Naz chart and not the Volume change! My bad, very bad. Glad you caught that.
Webby is like The Grateful Dead he so loves, just keeps on jamin’
No problem Pete. I just thought I might be looking at the wrong chart.
I felt good about today and put in a limit order to buy another 25% of a position in NFLX, but it did not fade enough to hit. Probably get a dip tomorrow.
I looked to add to YUMC also, but its vol was too low.
So, was this and FTD? Don’t know if Naz vol is finalized at 4:50, but hovering over the vol bar, it was just barely more than yesterday, so IBD should count that. The Naz barely didn’t rest the attempted rally and then it barely got enough vol for a FTD.
S&P: IBD does not use S&P index volume, I think because of all the index funds and other things that can distort it too much. I believe they use the NYSE composite volume, which looks much lower, but don’t know if it is finalized yet. Either way, they will tell us in an hour or so.
Non-IBD: I did sell a lot of my short term trade-around-the-core positions as they fell below 50dma. I have been slowly adding back to those position in last few days. Still uncertainty in my mind, so plenty more shares to add back. Will I get a did, will I buy back in time? never know, but buying these as “value” and not IBD, so really OT for this thread and board, but I like to think out loud and sometimes get feedback.
I think when I see a gap up and then no movement, something is up. and it is this…
RADNOR, Pa. and NEW YORK and BOSTON, Feb. 3, 2025 /PRNewswire/ – Triumph Group, Inc. (NYSE: TGI) (“TRIUMPH” or the “Company”) today announced that it has entered into a definitive agreement under which affiliates of growth-focused private equity firms Warburg Pincus and Berkshire Partners will acquire TRIUMPH through a newly formed entity for a total enterprise value of approximately $3 billion. Upon completion of the transaction, TRIUMPH will become a privately held Company, jointly controlled by Warburg Pincus and Berkshire Partners.
Under the terms of the agreement, TRIUMPH shareholders will receive $26.00 per share in cash. The purchase price represents a premium of approximately 123% over the Company’s unaffected closing stock price1 and a premium of approximately 58% over the volume weighted average price (VWAP) of TRIUMPH common stock for the 90 days prior to January 31, 2025.
1 Like
Good catch Pete thanks.
1 Like
I bought into CPRX, DOCS, Bros, BOW all on high volume
2 Likes
IBD evaluated 3 stocks in the video, all are worth at least a place on a watchlist.
HEI is in a Stage 1 cup with handle and just broke above a downtrend line, which they say could be an early entry spot with an add on a breakout. Very strong ratings. Good RS. Had a big gap up on earnings, then the market dragged it down, but not below 21dma. Now ready to break above that high and into the buy zone.
They said they discusses DASH on IBD Live and Alli did her favorite move, an early buy on a move above the 50dma. Current about 4.4% above that line. Sales growth has been very good, but EPS a has fluctuated.
BSX is more of a steady grower and is in a Stage 2 flat base. RS of 92 and pretty good ratings. The case can be made for an early buy today as it broke above a downtrend line and then a follow-on buy on a real breakout.
1 Like
3/25/25 - Today (including last night afterhours and this am pre-market), Pete started positions in BSX, HEI, DASH, DOCS, MELI and added to NFLX (all in IBD portfolio).
DASH and DOCS went above 50dma yesterday, so I used that as an early entry. DOCS has stellar ratings. HEI was with a buy-stop as it moved into the buy zone. MELI was with a buy stop as it reentered the buy zone after a huge earnings gap up and subsequent market drag-down starting 2/21. I feel like we are getting that gap back for “free”. NFLX was just exiting the buy zone, but I wanted more.
Yesterday, BSX moved above the 50dma and broke a downtrend line on the right side of a stage 2 flat base. Pretty good ratings too.
With DOCS, like NFLX, I am getting a second chance at a huge earnings gap up from early Feb. I mean, if you wished you had owned it the day before that, then why not buy it now.
The recommended exposure is 20-40% and these buys just put me around 25%.
Well, that did not last long. Had to sell DOCS as it plummeted below the 50dma. It was only a 1/8th position as an early buy off 50dma bounce. The iffy market kept me from buying bigger.
So I was assigned Meta at $537.50 and NVDA at $97.
Meta I had a delta of .1630 and NVDA I had a delta of .1270 I will be writing calls on both of them.
RDDT I had a strike of 85 and a delta of .0683 which held up I also had
Pltr at a strike of 72 and a delta of .0898 which held up barely.
Next week I have Pltr at a strike of 65 and a delta of .0545 but since it has dropped so much that might not hold up unless we get a bounce. I sold that put on thursday.
Friday I sold another Pltr put at a strike of 50 dollars and a delta of .0351 I suspect that one will hold. So with my covered calls and the Pltr put I suspect that I will get a nice return on Monday. I will write the calls at or slightly above the price I paid.
3 Likes
I sold a call on NVDA that I was assigned.
Strike price delta stock price
$97 $1.34 .2261 $87.91
I sold a call on Meta that was assigned
Strike price delta stock price
$537.50 $5.45 .1883 $484.83
3 Likes
Boy, how tempting does this long-term support seem for the Russell 2000 small caps (and IWM). Also looks like big magnet for now.
But when we get there, it will feel really bad and hard to buy.
2 Likes
Hey Pete do you get IBD Digital? If you do have you looked at the IBD Sector Leader list? There are only 3 on the list is that correct? Just trying to make sure I am in the correct spot. The product is a little confusing.
Ok I thought they would have a list of all the sectors and the head of each one.
No, the stock itself has to meet proper criteria. I think I have seen more than one stock from a sector as well.
1 Like